{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:39:05Z","timestamp":1784093945445,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1151-0","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T10:02:45Z","timestamp":1562320965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: the multifaceted consequences of PTPN11 mutations"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3187-0829","authenticated-orcid":false,"given":"Giulio","family":"Calcagni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Digilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"issue":"1","key":"1151_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13023-019-1010-z","volume":"14","author":"H Chen","year":"2019","unstructured":"Chen H, Li X, Liu X, Wang J, Zhang Z, Wu J, Huang M, Guo Y, Li F, Wang X, Fu L. Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort. Orphanet J Rare Dis. 2019;14(1):29\u2013019-1010-z.","journal-title":"Orphanet J Rare Dis"},{"key":"1151_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ijcard.2017.07.068","volume":"245","author":"G Calcagni","year":"2017","unstructured":"Calcagni G, Limongelli G, D'Ambrosio A, Gesualdo F, Digilio MC, Baban A, Albanese SB, Versacci P, De Luca E, Ferrero GB, Baldassarre G, Agnoletti G, Banaudi E, Marek J, Kaski JP, Tuo G, Russo MG, Pacileo G, Milanesi O, Messina D, Marasini M, Cairello F, Formigari R, Brighenti M, Dallapiccola B, Tartaglia M, Marino B. Cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results. Int J Cardiol. 2017;245:92\u20138.","journal-title":"Int J Cardiol"},{"key":"1151_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.dib.2017.11.085","volume":"16","author":"G Calcagni","year":"2017","unstructured":"Calcagni G, Limongelli G, D'Ambrosio A, Gesualdo F, Digilio MC, Baban A, Albanese SB, Versacci P, De Luca E, Ferrero GB, Baldassarre G, Agnoletti G, Banaudi E, Marek J, Kaski JP, Tuo G, Russo MG, Pacileo G, Milanesi O, Messina D, Marasini M, Cairello F, Formigari R, Brighenti M, Dallapiccola B, Tartaglia M, Marino B. Data on cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results. Data Brief. 2017;16:649\u201354.","journal-title":"Data Brief"},{"issue":"6","key":"1151_CR4","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.jtcvs.2018.06.040","volume":"156","author":"M Laredo","year":"2018","unstructured":"Laredo M, Khraiche D, Raisky O, Gaudin R, Bajolle F, Maltret A, Chevret S, Bonnet D, Vouhe PR. Long-term results of the modified Konno procedure in high-risk children with obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2018;156(6):2285\u201394 e2.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"10","key":"1151_CR5","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/j.febslet.2006.03.088","volume":"580","author":"N Hanna","year":"2006","unstructured":"Hanna N, Montagner A, Lee WH, Miteva M, Vidal M, Vidaud M, Parfait B, Raynal P. Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1. FEBS Lett. 2006;580(10):2477\u201382.","journal-title":"FEBS Lett"},{"issue":"4","key":"1151_CR6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.bbrc.2015.12.117","volume":"469","author":"S Noda","year":"2016","unstructured":"Noda S, Takahashi A, Hayashi T, Tanuma S, Hatakeyama M. Determination of the catalytic activity of LEOPARD syndrome-associated SHP2 mutants toward parafibromin, a bona fide SHP2 substrate involved in Wnt signaling. Biochem Biophys Res Commun. 2016;469(4):1133\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1151_CR7","doi-asserted-by":"publisher","first-page":"H231","DOI":"10.1152\/ajpheart.00665.2011","volume":"302","author":"C Schramm","year":"2012","unstructured":"Schramm C, Fine DM, Edwards MA, Reeb AN, Krenz M. The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling. Am J Physiol Heart Circ Physiol. 2012;302(1):H231\u201343.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"1151_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1086\/499925","volume":"78","author":"M Tartaglia","year":"2006","unstructured":"Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, Zampino G, Burgt I, Palleschi A, Petrucci TC, Sorcini M, Schoch C, Foa R, Emanuel PD, Gelb BD. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet. 2006;78(2):279\u201390.","journal-title":"Am J Hum Genet"},{"issue":"10","key":"1151_CR9","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1074\/jbc.M513068200","volume":"281","author":"MI Kontaridis","year":"2006","unstructured":"Kontaridis MI, Swanson KD, David FS, Barford D, Neel BG. PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects. J Biol Chem. 2006;281(10):6785\u201392.","journal-title":"J Biol Chem"},{"issue":"11","key":"1151_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00431-006-0163-7","volume":"165","author":"MC Digilio","year":"2006","unstructured":"Digilio MC, Sarkozy A, Pacileo G, Limongelli G, Marino B, Dallapiccola B. PTPN11 gene mutations: linking the Gln510Glu mutation to the \"LEOPARD syndrome phenotype\". Eur J Pediatr. 2006;165(11):803\u20135.","journal-title":"Eur J Pediatr"},{"issue":"7","key":"1151_CR11","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/ajmg.a.31156","volume":"140","author":"MC Digilio","year":"2006","unstructured":"Digilio MC, Sarkozy A, de Zorzi A, Pacileo G, Limongelli G, Mingarelli R, Calabro R, Marino B, Dallapiccola B. LEOPARD syndrome: clinical diagnosis in the first year of life. Am J Med Genet A. 2006;140(7):740\u20136.","journal-title":"Am J Med Genet A"},{"issue":"9","key":"1151_CR12","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1161\/CIRCULATIONAHA.108.792861","volume":"119","author":"LH Lehmann","year":"2009","unstructured":"Lehmann LH, Schaeufele T, Buss SJ, Balanova M, Hartschuh W, Ehlermann P, Katus HA. IMAGE CARDIO MED. A patient with LEOPARD syndrome and PTPN11 mutation. Circulation. 2009;119(9):1328\u20139.","journal-title":"Circulation"},{"issue":"1","key":"1151_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/0974-2069.79631","volume":"4","author":"M Ganigara","year":"2011","unstructured":"Ganigara M, Prabhu A, Kumar RS. LEOPARD syndrome in an infant with severe hypertrophic cardiomyopathy and PTPN11 mutation. Ann Pediatr Cardiol. 2011;4(1):74\u20136.","journal-title":"Ann Pediatr Cardiol"},{"issue":"4","key":"1151_CR14","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/ajmg.a.36982","volume":"167A","author":"A Hahn","year":"2015","unstructured":"Hahn A, Lauriol J, Thul J, Behnke-Hall K, Logeswaran T, Schanzer A, Bogurcu N, Garvalov BK, Zenker M, Gelb BD, von Gerlach S, Kandolf R, Kontaridis MI, Schranz D. Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: palliative treatment with a rapamycin analog. Am J Med Genet A. 2015;167A(4):744\u201351.","journal-title":"Am J Med Genet A"},{"issue":"8","key":"1151_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00431-005-1679-y","volume":"164","author":"K Takahashi","year":"2005","unstructured":"Takahashi K, Kogaki S, Kurotobi S, Nasuno S, Ohta M, Okabe H, Wada K, Sakai N, Taniike M, Ozono K. A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy. Eur J Pediatr. 2005;164(8):497\u2013500.","journal-title":"Eur J Pediatr"},{"issue":"7","key":"1151_CR16","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1007\/s00246-009-9473-7","volume":"30","author":"MF Faienza","year":"2009","unstructured":"Faienza MF, Giordani L, Ferraris M, Bona G, Cavallo L. PTPN11 gene mutation and severe neonatal hypertrophic cardiomyopathy: what is the link? Pediatr Cardiol. 2009;30(7):1012\u20135.","journal-title":"Pediatr Cardiol"},{"issue":"11","key":"1151_CR17","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1002\/ajmg.a.33713","volume":"152A","author":"M Derbent","year":"2010","unstructured":"Derbent M, Oncel Y, Tokel K, Varan B, Haberal A, Yazici AC, Legius E, Ozbek N. Clinical and hematologic findings in Noonan syndrome patients with PTPN11 gene mutations. Am J Med Genet A. 2010;152A(11):2768\u201374.","journal-title":"Am J Med Genet A"},{"issue":"11","key":"1151_CR18","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1136\/jmg.2004.021451","volume":"41","author":"B Keren","year":"2004","unstructured":"Keren B, Hadchouel A, Saba S, Sznajer Y, Bonneau D, Leheup B, Boute O, Gaillard D, Lacombe D, Layet V, Marlin S, Mortier G, Toutain A, Beylot C, Baumann C, Verloes A, Cave H, Collaborative F. Noonan study group: PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience. J Med Genet. 2004;41(11):e117.","journal-title":"J Med Genet"},{"issue":"1","key":"1151_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10038-004-0212-x","volume":"50","author":"K Kalidas","year":"2005","unstructured":"Kalidas K, Shaw AC, Crosby AH, Newbury-Ecob R, Greenhalgh L, Temple IK, Law C, Patel A, Patton MA, Jeffery S. Genetic heterogeneity in LEOPARD syndrome: two families with no mutations in PTPN11. J Hum Genet. 2005;50(1):21\u20135.","journal-title":"J Hum Genet"},{"issue":"3","key":"1151_CR20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1089\/gtmb.2009.0192","volume":"14","author":"AS Brasil","year":"2010","unstructured":"Brasil AS, Pereira AC, Wanderley LT, Kim CA, Malaquias AC, Jorge AA, Krieger JE, Bertola DR. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes. Genet Test Mol Biomarkers. 2010;14(3):425\u201332.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"10","key":"1151_CR21","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/ajmg.a.34194","volume":"155A","author":"Y Wakabayashi","year":"2011","unstructured":"Wakabayashi Y, Yamazaki K, Narumi Y, Fuseya S, Horigome M, Wakui K, Fukushima Y, Matsubara Y, Aoki Y, Kosho T. Implantable cardioverter defibrillator for progressive hypertrophic cardiomyopathy in a patient with LEOPARD syndrome and a novel PTPN11 mutation Gln510His. Am J Med Genet A. 2011;155A(10):2529\u201333.","journal-title":"Am J Med Genet A"},{"issue":"6","key":"1151_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000331266","volume":"1","author":"MC Digilio","year":"2011","unstructured":"Digilio MC, Lepri F, Baban A, Dentici ML, Versacci P, Capolino R, Ferese R, De Luca A, Tartaglia M, Marino B, Dallapiccola B. RASopathies: clinical diagnosis in the first year of life. Mol Syndromol. 2011;1(6):282\u20139.","journal-title":"Mol Syndromol"},{"issue":"36","key":"1151_CR23","doi-asserted-by":"publisher","first-page":"15436","DOI":"10.1073\/pnas.0903302106","volume":"106","author":"T Nakamura","year":"2009","unstructured":"Nakamura T, Gulick J, Pratt R, Robbins J. Noonan syndrome is associated with enhanced pERK activity, the repression of which can prevent craniofacial malformations. Proc Natl Acad Sci U S A. 2009;106(36):15436\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1151_CR24","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1161\/01.RES.0000186194.06514.b0","volume":"97","author":"M Krenz","year":"2005","unstructured":"Krenz M, Yutzey KE, Robbins J. Noonan syndrome mutation Q79R in Shp2 increases proliferation of valve primordia mesenchymal cells via extracellular signal-regulated kinase 1\/2 signaling. Circ Res. 2005;97(8):813\u201320.","journal-title":"Circ Res"},{"issue":"3","key":"1151_CR25","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1172\/JCI44972","volume":"121","author":"TM Marin","year":"2011","unstructured":"Marin TM, Keith K, Davies B, Conner DA, Guha P, Kalaitzidis D, Wu X, Lauriol J, Wang B, Bauer M, Bronson R, Franchini KG, Neel BG, Kontaridis MI. Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation. J Clin Invest. 2011;121(3):1026\u201343.","journal-title":"J Clin Invest"},{"issue":"6","key":"1151_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178905","volume":"12","author":"J Wang","year":"2017","unstructured":"Wang J, Chandrasekhar V, Abbadessa G, Yu Y, Schwartz B, Kontaridis MI. In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan syndrome with multiple lentigines-associated hypertrophic cardiomyopathy. PLoS One. 2017;12(6):e0178905.","journal-title":"PLoS One"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1151-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1151-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1151-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T23:11:31Z","timestamp":1593817891000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1151-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1151"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1151-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]},"assertion":[{"value":"11 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"163"}}